Alexion Pharmaceuticals Inc. Announces The Passing Of Max Link, Ph.D., Chairman Of The Company’s Board Of Directors

CHESHIRE, Conn.--(BUSINESS WIRE)--Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN) today announced that Max Link, Ph.D., Chairman of the Board of Directors of Alexion, passed away unexpectedly on October 5 while traveling on business. Dr. Link, a globally respected leader of companies in the pharmaceutical, biotechnology and medical device industries over the course of nearly four decades, served as a Director of Alexion since the Company was established in April 1992 and assumed the role of Chairman in December 2002. He was 74 years old.

Help employers find you! Check out all the jobs and post your resume.
MORE ON THIS TOPIC